SEC Form 4 · accession 0001179110-17-011866
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric A Rose M.D.
Director
Period of report
Aug 24, 2017
Accepted (ET)
Aug 28, 2017 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | Aug 24, 2017 | M | 12,000 | $18.63 | A | 24,652 | D | |
| Common Stock, $.01 par value | Aug 24, 2017 | M | 11,018 | $7.67 | A | 35,670 | D | |
| Common Stock, $.01 par valueF2 | Aug 24, 2017 | S | 10,397 | $150.3999 | D | 25,273 | D | |
| Common Stock, $.01 par valueF3 | Aug 24, 2017 | S | 11,021 | $151.5384 | A | 14,252 | D | |
| Common Stock, $.01 par valueF4 | Aug 24, 2017 | S | 1,600 | $152.4231 | D | 12,652 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.63 | Aug 24, 2017 | M | 12,000 | D | Aug 13, 2009 | Aug 13, 2018 | Common Stock | 12,000 | 0 | D |
| Stock Option (right to buy)F1 | $7.67 | Aug 24, 2017 | M | 11,018 | D | Aug 12, 2010 | Aug 12, 2019 | Common Stock | 12,000 | 982 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $150.0000 and $150.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F3This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $151.0200 and $152.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F4This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $152.0200 and $153.3100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer..